Screening of traditional Chinese medicine monomers as ribonucleotide reductase M2 inhibitors for tumor treatment

BACKGROUND: Ribonucleotide reductase (RR) is a key enzyme in tumor proliferation, especially its subunit-RRM2. Although there are multiple therapeutics for tumors, they all have certain limitations. Given their advantages, traditional Chinese medicine (TCM) monomers have become an important source o...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Ya-Ya, Feng, Song, Zhang, Xiao-Dong, Peng, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Clinical and Translational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649558/
https://www.ncbi.nlm.nih.gov/pubmed/36387821
http://dx.doi.org/10.12998/wjcc.v10.i31.11299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649558/
https://www.ncbi.nlm.nih.gov/pubmed/36387821
http://dx.doi.org/10.12998/wjcc.v10.i31.11299

Ejemplares similares